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LIDOCAINE INDUCES ROCK-DEPENDENT MEMBRANE BLEBBING AND
CELL DEATH IN RABBIT ARTICULAR CHONDROCYTE
T. Maeda y,z, S. Imai y, F. Toyoda z, H. Tanigawa y,z, K. Kumagai y,z,
H. Matsuura z, Y. Matsusue y. yDept. of Orthopedic Surgery, Shiga Univ. of
Med. Sci., Otsu, Shiga, Japan; zDept. of Physiology, Shiga Univ. of Med. Sci.,
Otsu, Shiga, Japan
Purpose: Local anesthetics are administered intraarticularly for pain
control in orthopedic clinics and surgeries. Although previous studies
have shown that local anesthetics can be toxic to chondrocytes, the
underlying mechanism remains unclear. The present study was
undertaken to investigate the cellular mechanisms associated with
lidocaine-induced toxicity to articular chondrocytes.
Methods: Isolated rabbit articular chondrocytes were exposed for 30
minutes to lidocaine at concentrations of 1, 3, 10 and 30 mM (360
mosmol$L-1, pH 6.8, 7.4 and 8.7) at 36 C. To evaluate the lidocaine-
induced blebbing, morphological changes of chondrocytes were
monitored using time-lapse microscopy and then the percentage of
blebbing cells was evaluated every minute. The levels of guanosine
triphosphate (GTP)-bound RhoA and caspase-3 were determined using
a RhoA G-LISA assay and a Caspase-Glo 3/7 assay. The viability of
chondrocytes treated with 30 mM lidocaine for an hour was deter-
mined using a LIVE/DEAD® assay kit. To evaluate the percentage of
living cells, the number of living cells (green) and dead cells (red) of
each image were counted by an ImageJ software.
Results: Treatment of chondrocytes with lidocaine caused spherical
protrusions on the cell surface (so called ‘membrane blebbing’) in a
time- and concentration-dependent manner. After 30-min exposure,
lidocaine (pH 7.4) at the concentrations of 1, 3, 10 and 30 mM induced
membrane blebbing in 9.6±1.1%, 35.5±11.6%, 84.1±2.2% and 100±0% of
chondrocytes, respectively, compared with the controls (1.2±2.1%)
(mean±s.d., n¼3). These effects of lidocaine could be ﬁtted by the Hill
equation giving an EC50 of 4.13 mM, which is lower than clinical use
concentrations. When lidocaine was applied under alkaline (pH8.7) or
acidic (pH 6.8) condition, the EC50s were shifted to 1.37 or 11.72 mM,
respectively, as is expected for the pH-dependent change in the con-
centration of non-ionized lidocaine. ROCK (Rho-kinase) inhibitors Y-
27632 (10 mM) and fasudil (100 mM) completely inhibited the lidocaine-
induced membrane blebbing, suggesting that ROCK activation is
required for the blebbing. Although the apoptotic blebbing is typically
caused by the caspase-3-induced cleavage of ROCK-I, the caspase-3
level was unchanged by 20-min treatment of chondrocytes with 10 mM
lidocaine. Furthermore, although it was reported that apoptotic bleb-
bing was abrogated by z-VAD-fmk, a caspase inhibitor, this drug did not
prevent the lidocaine-induced blebbing. These results suggest that
lidocaine-induced membrane blebbing is independent of caspase-3
activity. The GTP-bound RhoA level was signiﬁcantly increased
(3.01±0.76 folds, P < 0.0001) by 20-min treatment of chondrocytes with
10 mM lidocaine. However, Rho inhibitor-1 rather enhanced the
membrane blebbing, suggesting that the lidocaine-induced membrane
blebbing might be at least partially mediated through the pathway
other than canonical Rho/ROCK signaling. Chondrocyte viability was
signiﬁcantly decreased to 17.6±5.7% after 1-h exposure to 30 mM
lidocaine, compared with the control viability of 94.8±2.4% (P <
0.0001). Pretreatment with Y-27632 or fasudil for 1-hour attenuated
the lidocaine induced-cytotoxicity (49.4±12.5% and 47.2±9.1% viability
respectively, P < 0.0001), demonstrating that the lidocaine-induced
hyperactivation of ROCK leaded to chondrotoxicity.
Conclusions: These ﬁndings show that lidocaine induces a cytotoxic
effect on chondrocytes through the mechanism involving membrane
bleb formation and ROCK activation and that caution should be taken
when administering lidocaine intraarticularly.
187
INTERLEUKIN-1BETA IS ESSENTIAL FOR BLOOD-INDUCED
CARTILAGE DAMAGE IN VITRO
L.F. van Vulpen, K. Coeleveld, R.E. Schutgens, E.C. Alsema,
G. Roosendaal, S.C. Mastbergen, F.P. Lafeber. UMC Utrecht, Utrecht,
Netherlands
Purpose: Exposure of joint cartilage to blood can occur after joint
trauma, during or after major joint surgery, or due to hemophilia. This
ultimately leads to joint damage, having both the inﬂammatory char-
acteristics of rheumatoid arthritis and the degenerative characteristicsof osteoarthritis. We previously reported that blocking interleukin(IL)-
1b with a recombinant monoclonal antibody (IL-1bmAb) protects car-
tilage from the damaging effects of blood exposure in a dose-dependent
way (Abstract 155; 2014 World Congress on Osteoarthritis). To further
unravel the role of IL-1b in blood-induced cartilage damage, we
investigated whether blocking IL-1 with a receptor antagonist (IL-1RA)
is also able to prevent blood-induced cartilage damage in vitro, and
whether blocking IL-1b with either IL-1RA or IL-1bmAb after onset of a
bleed is still beneﬁcial.
Methods: Healthy human cartilage explants were cultured for 4 days in
presence/absence of 50% whole blood. IL-1RA was added in a broad
concentration range (10-1000 ng/mL) during blood exposure (n¼7).
Furthermore, IL-1bmAb (100 ng/mL) or IL-1RA (1000 ng/mL) was
administered directly or after a delay of several hours up to 2 days
(n¼7). Proteoglycan turnover was determined after a recovery period of
12 days.
Moreover, in 4-day whole blood cultures (n¼6) the effects of IL-1bmAb
(100 ng/mL) and IL-1RA (1000 ng/mL) on the levels of IL-1b, IL-6, and
TNF-a were determined.
Results: Exposure of cartilage to blood severely impacted proteoglycan
turnover (PG synthesis -76%; p¼0.018 see ﬁgure A; PG release þ125%;
p¼0.018; PG content -18%; p¼0.028; all compared to control). Addition
of IL-1RA resulted in a clear dose-dependent improvement in proteo-
glycan turnover (see ﬁgure A for proteoglycan synthesis). For PG release
and PG content, the highest concentration led to normalisation as
compared to control (PG release þ33% of control (p¼0.063); PG content
þ2% of control (p¼0.866)). The protective effect of IL-1bmAb or IL-1RA
was most pronounced when administered within 8 hours after the
bleed (see ﬁgure B for proteoglycan synthesis upon IL-1RA addition).
Blocking IL-1b reduced IL-6 (21 347 pg/mL in whole blood culture
versus 27 pg/mL and 289 pg/mL after addition of IL-1RA and IL-1bmAb
(both p¼0.028)) and IL-1b (74 pg/mL in whole blood culture versus
undetectable after addition of IL-1RA, p¼0.028) levels in whole blood
cultures, but did not affect the levels of TNF-a (35 pg/mL inwhole blood
culture versus 37 pg/mL after addition of IL-1RA or IL-1bmAb (both
p¼0.753)).
Conclusions: This study demonstrates that IL-1b is a critical factor in
the development of blood-induced cartilage damage in vitro. Blocking it
with either a monoclonal antibody or receptor antagonist protects
cartilage from the damaging effects of blood exposure in a dose- and
time-dependent way. Early administration after blood-exposure is most
beneﬁcial. This key role of IL-1b results at least partly from regulating
the production of other pro-inﬂammatory cytokines, including IL-1b
itself and IL-6. As therapeutic agents opposing the activity of IL-1b are
readily available, further research is warranted to investigate its in vivo
capacity in prevention and treatment of joint damage upon joint
bleeding.
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THE ROLE OF SODIUM HYDROGEN EXCHANGER REGULATORY
FACTOR 1 IN OSTEOARTHRITIS
R. White, M.C. Blair, F.R. Saunders, R.M. Aspden. Univ. of Aberdeen,
Aberdeen, United Kingdom
Purpose: In a pilot study, selected gene expression in tissue samples
from patients with OA and osteoporosis (OP) were compared. The gene,
SLC9A3R1 which encodes for a member of the sodium/hydrogen reg-
ulatory factor protein family (NHERF1) was found to be differentially
expressed in osteoblasts. NHERF1 plays a role in tumour suppression,
via PTEN, and intracellular pH (pHi) regulation by acting on the sodium/
hydrogen exchanger (NHE). We are investigating whether a decrease in
NHERF1 causes a change in the pHi of chondrocytes and leads to
